市場調查報告書

止血口才的全球市場:成長率,趨勢及預測

Hemostasis Valve Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921978
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
止血口才的全球市場:成長率,趨勢及預測 Hemostasis Valve Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

本報告提供全球止血口才市場相關調查分析,提供市場概要,市場動態,市場區隔,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

  • 調查的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 干預次序的增加
    • 慢性疾病的發生率上升
  • 市場阻礙因素
    • 設備的使用和監視相關問題
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭力的強度

第5章 市場區隔

  • 各產品類型
    • 止血閥Y連接器
    • 雙Y型接頭止血閥
    • 單止血閥
    • 其他
  • 各用途
    • 血管造影術
    • 血管成形術
  • 各終端用戶
    • 醫院
    • 其他的終端用戶
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲地區
    • 南美

第6章 競爭情形

  • 公司概要
    • Boston Scientific Corporation
    • Merit Medical Systems
    • Teleflex Incorporated
    • Terumo Corporation
    • Freudenberg Medical
    • Argon Medical Devices
    • B. Braun Melsungen AG
    • Antmed Corporation
    • Abbott
    • DeRoyal Industries, Inc.

第7章 市場機會及未來趨勢

目錄
Product Code: 67516

Market Overview

The significant factor attributing this market's growth is the increasing number of interventional procedures and surgical procedures worldwide. The rising pool of patients with different illnesses and rising demand for intensive hemostasis devices is also fuelling the market growth. Heart disease is the world's major cause of death and accounted for 17.9 million fatalities in 2016, according to the WHO (WORLD HEALTH ORGANIZATION) published data. Worldwide, the growth of the geriatric population has led to increased cardiovascular disease prevalence. Since 2011, the medical devices industry has seen an annual growth rate of around 4.5 percent. Rising occurrences of cardiovascular illnesses and an increase in the aging population have a significant impact on the growth of the market for the Hemostasis valve.

Scope of the Report

Hemostasis valves enable medical providers by giving them flexibility in catheters and delivery systems of the next generation. If a catheter is inserted into a body for angiography or other applications, the hemostasis valve is the device that avoids blood reflux.

Key Market Trends

Hospitals are Expected to Hold the Largest Market Share in the Hemostasis Valve Market

  • Dominant share is retained by the Hospital segment owing to the attributes such as growing hospital numbers in the developing countries due to the development of healthcare infrastructure.
  • Facilities such as healthy food, supportive services, a friendly environment, and patient safety, will play a significant role in upsurging the demand for the hospitals. As per the (NBER) NATIONAL BUREAU OF ECONOMIC RESEARCH Cambridge, improved facilities drive up the demand for hospitals by an average of 38.4 percent.
  • Hospitals are probably to see a huge surge of new patients as healthcare reform comes into force effortlessly, and governments are introducing new policies to optimizing patient flows.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall Hemostasis Valve market, throughout the forecast period. This is owing to factors like the rising prevalence of chronic disorders such as infectious diseases and the geriatric population. The cardiovascular disease stays the major cause of fatalities in the US, which in 2016 resulted in 840,768 fatalities (635,260 cardiac). Between 2006 and 2016, the death rate from CVD in the United States declined by 18.6% and 31.8% from coronary heart disease, according to the American College of Cardiology Foundation, Feb 2019. Coronary events are expected to occur in the United States in 2019 in around 1,055,000 Americans, along with 335,000 reoccurring and 720,000 new coronary incidents which are further expected to upsurge the demand of hemostasis devices in the market during the forecast period owing to the growth in the number of cardiac surgery.

Competitive Landscape

The Hemostasis Valve market is moderately competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and new product launches with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Merit Medical Systems, Teleflex Incorporated, Terumo Corporation, and Freudenberg Medical.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 The increase in the number of interventional procedures
    • 4.2.2 Rising incidence of chronic diseases
  • 4.3 Market Restraints
    • 4.3.1 Difficulties related to its use and supervision of these devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Hemostasis Valve Y-Connectors
    • 5.1.2 Double Y-Connector Hemostasis Valves
    • 5.1.3 One-Handed Hemostasis Valves
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Angiography
    • 5.2.2 Angioplasty
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Merit Medical Systems
    • 6.1.3 Teleflex Incorporated
    • 6.1.4 Terumo Corporation
    • 6.1.5 Freudenberg Medical
    • 6.1.6 Argon Medical Devices
    • 6.1.7 B. Braun Melsungen AG
    • 6.1.8 Antmed Corporation
    • 6.1.9 Abbott
    • 6.1.10 DeRoyal Industries, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS